Factors that Affect Disease Progression
Mutations in HIV Co-receptors
Most strains of HIV use a co-receptor molecule called CCR5, in addition to the CD4
molecule, to infect a cell. Other HIV strains use a different co-receptor known
as CXCR4 to attack cells. Both receptors enable the virus to enter a cell during
the initial stage of HIV infection.
Studies have shown that people infected with HIV who have specific genetic mutations
in one of their two copies of the CCR5 gene progress to AIDS slower than people
with two normal copies of the CCR5 gene. There are also rare individuals with two
mutant copies of the CCR5 gene who appear, in most cases, to be completely protected
from HIV infection. Gene mutations in other HIV co-receptors such as CXCR4 also
may influence the rate of disease progression.
High Viral Load
The amount of HIV in a person’s blood often is called his or her viral load. People
with high viral loads are more likely to progress to AIDS faster than people with
lower levels of the virus. In addition, research has shown that the level of HIV
in a person’s blood after the first few months of infection, known as the viral
set point, also influences the speed of progression to AIDS. Those with higher viral
set point are much more likely to get sick faster than those with lower viral set
point.
Highly active antiretroviral therapy (HAART), which is a potent combination
of three or more antiretroviral drugs belonging to at least two different antiretroviral
drug classes, can help lower the viral load and viral set point for those infected
with HIV. For many people, HAART delays the progression to AIDS for a prolonged
period of time.
Information published courtesy of
NIAID
This article was last modified in: 06/18/2012